Current Status on the Epidemiology of Hepatitis B Virus Infection in İstanbul İstanbul’daki Hepatit B Virüsü Enfeksiyonunun Epidemiyolojisine İlişkin Mevcut Durum
Mediterranean Journal of Infection, Microbes and Antimicrobials, cilt.14, sa.1, 2025 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 14 Sayı: 1
- Basım Tarihi: 2025
- Doi Numarası: 10.4274/mjima.galenos.2025.24364.10
- Dergi Adı: Mediterranean Journal of Infection, Microbes and Antimicrobials
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Anahtar Kelimeler: Hepatitis B virus, acute hepatitis B, hepatitis B vaccine, seroprevalence, & Idot;stanbul
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Introduction: Despite the availability of safe and effective vaccines against Hepatitis B virus (HBV), the infection remains a significant global health issue. This study examined all serological markers of HBV at the largest hospital in İstanbul to identify hepatitis B cases and assess current seroprevalence. Materials and Methods: Data from cases analyzed between May 2020 and October 2023 included the following parameters: hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), antibody to hepatitis B surface antigen (anti-HBs), antibody to hepatitis B e antigen (anti-HBe), IgM antibody to hepatitis B core antigen (anti-HBc IgM), and total antibody to hepatitis B core antigen (anti-HBc total), all measured using the Roche cobas e 801 analyzer. Results: HBsAg positivity was detected in 2.11% of 467,163 patients. Among 39,046 children, the HBsAg positivity rate was 0.47%. The highest HBsAg positivity was observed in the 51-60 age group. Acute hepatitis B, indicated by anti-HBc IgM positivity, was identified in 0.41% of 17,293 patients. Among those who tested positive for HBsAg, 1.90% were also positive for HBeAg. Anti-HBs was positive in 46.27% of 294,631 patients overall and in 67.35% of 44,293 children. The highest anti-HBs positivity was observed in the <1 year and 1-5 year age groups. The lowest positivity rates for both HBsAg and anti-HBs were recorded in 2023. Conclusion: With an HBsAg positivity rate of 2.11%, the region can be classified as having intermediate endemicity. This study aims to support seroprevalence assessments by providing updated data, contributing to efforts toward hepatitis B control goals.